NMC
NEA Management Company Portfolio holdings
AUM
$1.33B
1-Year Return
85.82%
This Quarter Return
+24.44%
1 Year Return
+85.82%
3 Year Return
+531.37%
5 Year Return
+304.32%
10 Year Return
+4,927.96%
AUM
$1.78B
AUM Growth
-$224M
(-11%)
Cap. Flow
-$160M
Cap. Flow
% of AUM
-9.01%
Top 10 Holdings %
Top 10 Hldgs %
64.26%
Holding
62
New
5
Increased
1
Reduced
29
Closed
5
Top Buys
Top Sells
| 1 |
Arcellx
ACLX
|
$62.1M |
| 2 |
IonQ
IONQ
|
$40.5M |
| 3 |
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
|
$32.5M |
| 4 |
AKUS
Akouos, Inc. Common Stock
AKUS
|
$29.1M |
| 5 |
IVA
Inventiva
IVA
|
$19.7M |
Sector Composition
| 1 | Healthcare | 71.35% |
| 2 | Consumer Staples | 10.55% |
| 3 | Technology | 10.5% |
| 4 | Industrials | 7.01% |
| 5 | Communication Services | 0.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Aurinia Pharmaceuticals
AUPH
$1.65B
| $17.1M | 0.96% |
3,969,834
| – | – |
|
27
X4 Pharmaceuticals
XFOR
$81.7M
| $11.7M | 0.65% |
391,226
+173,787
| +80% | +$5.18M |
|
|
OKUR
28
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$36.4M
| $11.2M | 0.63% |
478,549
-143
| -0% | -$3.33K |
|
29
BuzzFeed
BZFD
$68.5M
| $10.6M | 0.59% |
3,833,473
| – | – |
|
30
FiscalNote
NOTE
$57.5M
| $9.65M | 0.54% |
141,194
| – | – |
|
|
TUYA
31
Tuya Inc
TUYA
$1.51B
| $9.43M | 0.53% |
4,934,640
| – | – |
|
32
Champions Oncology
CSBR
$95.4M
| $7.73M | 0.43% |
1,713,720
| – | – |
|
33
Gossamer Bio
GOSS
$571M
| $7.52M | 0.42% |
3,467,406
| – | – |
|
|
IVA
34
Inventiva
IVA
$779M
| $7M | 0.39% |
1,462,586
-4,110,367
| -74% | -$19.7M |
|
35
BILL Holdings
BILL
$4.75B
| $6.84M | 0.38% |
66,070
-30
| -0% | -$3.11K |
|
36
Black Diamond Therapeutics
BDTX
$163M
| $6.21M | 0.35% |
3,448,757
-1,088
| -0% | -$1.96K |
|
|
AFMD
37
DELISTED
Affimed
AFMD
| $5.49M | 0.31% |
442,649
| – | – |
|
38
Senti Biosciences
SNTI
$36.1M
| $5.35M | 0.3% |
442,615
-358
| -0.1% | -$4.32K |
|
39
Lexicon Pharmaceuticals
LXRX
$389M
| $4.55M | 0.26% |
2,382,286
| – | – |
|
40
Acrivon Therapeutics
ACRV
$40.9M
| $4.44M | 0.25% |
+481,677
| New | +$4.44M |
|
41
Xeris Biopharma Holdings
XERS
$1.27B
| $4.32M | 0.24% |
3,246,785
| – | – |
|
42
Synlogic
SYBX
$17.1M
| $3.21M | 0.18% |
281,929
-32
| -0% | -$365 |
|
43
Marker Therapeutics
MRKR
$11.1M
| $2.85M | 0.16% |
1,071,429
| – | – |
|
|
STSA
44
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
| $2.69M | 0.15% |
2,992,958
-150,000
| -5% | -$135K |
|
|
EAR
45
DELISTED
Eargo, Inc. Common Stock
EAR
| $2.6M | 0.15% |
226,010
-32
| -0% | -$368 |
|
|
INZY
46
DELISTED
Inozyme Pharma
INZY
| $2.56M | 0.14% |
2,437,689
-6,690
| -0.3% | -$7.03K |
|
|
UTRS
47
DELISTED
Minerva Surgical, Inc. Common Stock
UTRS
| $2.23M | 0.13% |
499,956
-141
| -0% | -$630 |
|
48
MEI Pharma
MEIP
$140M
| $2.08M | 0.12% |
426,654
| – | – |
|
|
RGLS
49
DELISTED
Regulus Therapeutics
RGLS
| $1.98M | 0.11% |
1,445,114
-1
| -0% | -$1 |
|
|
MIMO
50
DELISTED
Airspan Networks Holdings Inc.
MIMO
| $1.81M | 0.1% |
1,382,300
-152,333
| -10% | -$200K |
|